ORI
KERX

Oak Ridge Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Oak Ridge Investments’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,140,071
Closed -$11.1M – 151
2015
Q3 		$11.1M Sell
3,140,071
-151,640
-5% -$1.02M 0.26% 92
2015
Q2 		$32.9M Buy
3,291,711
+4,867
+0.1% +$52.2K 0.7% 51
2015
Q1 		$41.8M Buy
3,286,844
+38,854
+1% +$499K 0.94% 39
2014
Q4 		$46M Sell
3,247,990
-15,538
-0.5% -$241K 1.1% 38
2014
Q3 		$44.9M Buy
3,263,528
+1,181,736
+57% +$18.1M 1.17% 34
2014
Q2 		$32M Buy
2,081,792
+14,739
+0.7% +$209K 0.76% 49
2014
Q1 		$35.2M Buy
+2,067,053
New +$31.2M 0.88% 45

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oak Ridge Investments's KERX Position: Q4 2015 in Review

Oak Ridge Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2015, closing a stake of 3,140,071 shares — an estimated $11.1M sold.

Oak Ridge Investments first reported a position in KERX in Q1 2014 and held it in 7 quarters. The position peaked at $46M in Q4 2014. 128 funds tracked by Wall St. Rank hold KERX as of Q4 2015.

  • Oak Ridge Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Oak Ridge Investments sold 3,140,071 Keryx Biopharmaceuticals Inc shares in Q4 2015, an estimated $11.1M.
  • Oak Ridge Investments first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 7 quarters.
  • Oak Ridge Investments's Keryx Biopharmaceuticals Inc position peaked at $46M in Q4 2014.
  • 128 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2015.

Based on Oak Ridge Investments's 13F filing for Q4 2015, filed 1 Feb 2016.